Leaflet IRROPIA 20mg orodispersible tablets
Product code: W57755001 Quantity: 28
Indicated for: schizophrenia; bipolar disorder
Route of administration: oral
Substance: olanzapine (antipsychotic)
ATC: N05AH03 (Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
This medicine may increase the risk of seizures.
This medicine may cause drowsiness or reduced alertness.
Olanzapine is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. It works by blocking dopamine and serotonin receptors in the brain, helping to reduce psychotic symptoms and stabilize mood.
The medication is taken orally, usually once daily, as directed by a doctor. The dosage is adjusted based on the patient's response and the severity of the condition.
Patients should be aware of potential side effects, such as weight gain, drowsiness, or dizziness. It is important to inform the doctor of any unusual symptoms or the use of other medications.
Common side effects include weight gain, drowsiness, dizziness, and dry mouth. In rare cases, severe reactions such as neuroleptic malignant syndrome or hyperglycemia may occur. Patients should be informed of these risks before starting treatment.
General data about IRROPIA 20mg
- Substance: olanzapine
- Date of latest medicines list: 01-05-2018
- Product code: W57755001
- Concentration: 20mg
- Pharmaceutical form: orodispersible tablets
- Quantity: 28
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for olanzapine
Concentrations available for olanzapine
- 10mg
- 15mg
- 2.5mg
- 20mg
- 210mg
- 300mg
- 405mg
- 5mg
- 7.5mg